Researchers from the University of Oxford are collaborating with the Japanese pharmaceutical company, SBI Pharmaceuticals, to minimise deterioration of heart function outcomes after cardiac surgery.
A volunteer who has been taking part in a heart imaging study at the Oxford Centre for Magnetic Resonance Research (OCMR), has kindly donated \u00a3500 to support further work in the Centre.
Prof Paul Leeson, Head of Oxford Cardiovascular Clinical Research Facility will talk about links between the cardiovascular health of the mother and their child, at a free Oxford BRC public meeting.
Congratulations to Marios Margaritis and Rohan Wijesurendra, who have won this year\u2019s RDM Graduate Studies Prize. Both students showed immense dedication in their studies and have made significant findings in our understanding of cardiovascular disease.
The largest NHS-based centre to identify genetic causes of heart disease has welcomed its 10,000th patient. Founded by Oxford University and NHS staff, the Oxford Medical Genetics Laboratory at the Churchill Hospital began its cardiac genetic testing service in 2003 and was the first accredited NHS diagnostic genetic testing service for inherited cardiac conditions (ICC) in the UK.
A groundbreaking study, led by experts from the University of Oxford and Royal Brompton Hospital, has discovered better methods to interpret the significance of gene mutations in patients who are tested for genetic conditions. The findings mean that, in future, more diagnoses could be made through genetic testing.
How can chemistry help us tackle heart disease \u2013 one of our greatest medical challenges? We are teaming up with the Department of Chemistry to showcase pioneering heart disease research taking place in Oxford.
Breastfeeding premature babies improves long-term heart structure and function, Dr Adam Lewandowski and colleagues in the Cardiovascular Clinical Research Facility have found.
Dr Victoria Stoll was awarded the Early Career Award for Translational CMR at the 19th Annual Scientific Sessions of the Society for Cardiovascular Medicine.
Dr Luca Biasiolli at the university has been backed by the British Heart Foundation to study whether a new MRI scanning technique could be used to spot the potentially dangerous plaques that cause stroke.
![\"JUDGES'](\"https://www.rdm.ox.ac.uk/news/oxford-academics-partner-with-sbi-pharmaceuticals-to-improve-cardiac-surgery/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n